EURETINA Innovation Spotlight (EIS)
Sep 18, 2024
Session 5: VEGF-related and other retinal indications (4:00 – 4:35 pm CEST)
Presentation: Sozinibercept in wet AMD: Potential for superior vision outcomes beyond anti-VEGF-A therapies
Presenter: Frederic Guerard, PharmD, CEO
Presentation: Sozinibercept in wet AMD: Potential for superior vision outcomes beyond anti-VEGF-A therapies
Presenter: Frederic Guerard, PharmD, CEO